Literature DB >> 1667298

The value of prescribed 'high-fibre' diets for the treatment of the irritable bowel syndrome.

J P Lambert1, P W Brunt, N A Mowat, C C Khin, C K Lai, V Morrison, J W Dickerson, M A Eastwood.   

Abstract

The symptoms of 72 patients with irritable bowel syndrome were assessed by questionnaire before and 6 months after a high-fibre diet had been prescribed, to find whether those who achieved the highest fibre intake did any better than those with smaller intakes. Dietary fibre intakes were measured after 6 months by a 7-day weighed food inventory. There was a significant inverse association between the presence of symptoms and fibre intake for: incomplete defaecation, urgency and hard stools with total fibre intake; urgency and hard stools with cereal fibre intake; and borborygmi with fibre intake at breakfast. All patients with constipation, mucus, urgency or watery stools at the beginning of the study, and who were consuming more than 30 g fibre by the end, reported an improvement in these symptoms. Increasing intakes of fibre were not related in any way to abdominal distension, diarrhoea, flatulence or patient's feelings about the working of their bowels. Therefore, this study suggests that the symptoms which benefit most from the prescription of a high-fibre diet are hard stools, constipation and urgency.

Entities:  

Mesh:

Year:  1991        PMID: 1667298

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  6 in total

Review 1.  Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.

Authors:  P Paré; Ronald Bridges; Malcolm C Champion; Subhas C Ganguli; James R Gray; E Jan Irvine; Victor Plourde; Pierre Poitras; Geoffrey K Turnbull; Paul Moayyedi; Nigel Flook; Stephen M Collins
Journal:  Can J Gastroenterol       Date:  2007-04       Impact factor: 3.522

Review 2.  Drug treatment options for irritable bowel syndrome: managing for success.

Authors:  R C Dunphy; G N Verne
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  Does a self-management program change dietary intake in adults with irritable bowel syndrome?

Authors:  Hsiu-Feng Hsueh; Monica E Jarrett; Kevin C Cain; Robert L Burr; Wimon Deechakawan; Margaret M Heitkemper
Journal:  Gastroenterol Nurs       Date:  2011 Mar-Apr       Impact factor: 0.978

Review 4.  Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.

Authors:  Lisa Ruepert; A Otto Quartero; Niek J de Wit; Geert J van der Heijden; Gregory Rubin; Jean Wm Muris
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

5.  Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults.

Authors:  Philip A Waller; Pramod K Gopal; Gregory J Leyer; Arthur C Ouwehand; Cheryl Reifer; Morgan E Stewart; Larry E Miller
Journal:  Scand J Gastroenterol       Date:  2011-06-13       Impact factor: 2.423

Review 6.  The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence.

Authors:  Joost Algera; Esther Colomier; Magnus Simrén
Journal:  Nutrients       Date:  2019-09-09       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.